Narrow QRS HF Patients Assessed by ECG Belt
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03367104 |
Recruitment Status :
Completed
First Posted : December 8, 2017
Last Update Posted : September 23, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Heart Failure Cardiac Resynchronization Therapy | Device: ECG Belt |
Study Type : | Observational |
Actual Enrollment : | 10 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Electrical Dyssynchrony in Narrow QRS Heart Failure Patients as Assessed by the ECG Belt |
Actual Study Start Date : | November 14, 2017 |
Actual Primary Completion Date : | August 17, 2021 |
Actual Study Completion Date : | August 17, 2021 |

Group/Cohort | Intervention/treatment |
---|---|
Normal healthy controls |
Device: ECG Belt
Assess electrical dyssynchrony with an anterior-posterior body surface mapping system. |
Heart failure patients |
Device: ECG Belt
Assess electrical dyssynchrony with an anterior-posterior body surface mapping system. |
- Electrical dyssynchrony quantification [ Time Frame: through acute study completion (~60 minutes) ]Collect ECG data with ECG Belt

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Subject (or their legal guardian) must be willing to provide informed consent for their participation in the study
- Subject ≥ 18 years old
Exclusion Criteria:
- Subject has unhealed-open wounds on the torso and/or has a history of severe allergic reactions from ECG electrode gel
- Subject is enrolled in a concurrent study that could confound the results of this study
- Subject is pregnant

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03367104
United States, Minnesota | |
United Heart & Vascular Clinic | |
Saint Paul, Minnesota, United States, 55102 |
Principal Investigator: | Alan Bank, MD | Allina Health System |
Responsible Party: | Alan J. Bank, MD, Medical Director of Research - UHVC, Allina Health System |
ClinicalTrials.gov Identifier: | NCT03367104 |
Other Study ID Numbers: |
ERP 3771 |
First Posted: | December 8, 2017 Key Record Dates |
Last Update Posted: | September 23, 2021 |
Last Verified: | September 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Device Product Not Approved or Cleared by U.S. FDA: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
Heart Failure Heart Diseases Cardiovascular Diseases |